Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grassroots Cannabis is a leading multi-state cannabis operator in the United States, focused on the cultivation, processing, and dispensing of medical and adult-use cannabis products. The company operates a diverse portfolio of brands and retail locations, providing high-quality cannabinoid-based therapies for various medical indications including chronic pain and epilepsy. Founded in 2014 and headquartered in Chicago, Grassroots established a significant footprint across several states before its acquisition by Curaleaf in 2020. The company's business model integrates vertical operations to ensure product consistency and patient access to therapeutic cannabis modalities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grass Roots.